Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platelet response and clopidogrel bioavailability in NSTEACS
2012-003125-24Phase 4Completed
- Sponsor
- Azienda Ospedaliera Universitaria Integrata Verona
- Start
- Sep 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of clopidogrel and aspirin in acute coronary syndrome (ACS), sponsored by Azienda Ospedaliera Universitaria Integrata Verona. Primary endpoint: Platelet Reactivity Index. Started Sep 2012; status: completed.
02
Drugs
clopidogrelaspirin
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on 2012-003125-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003125-24.